Aging Affects the Transcriptional Regulation of Human Skeletal Muscle Disuse Atrophy

Important insights concerning the molecular basis of skeletal muscle disuse-atrophy and aging related muscle loss have been obtained in cell culture and animal models, but these regulatory signaling pathways have not previously been studied in aging human muscle. In the present study, muscle atrophy was induced by immobilization in healthy old and young individuals to study the time-course and transcriptional factors underlying human skeletal muscle atrophy. The results reveal that irrespectively of age, mRNA expression levels of MuRF-1 and Atrogin-1 increased in the very initial phase (2–4 days) of human disuse-muscle atrophy along with a marked reduction in PGC-1α and PGC-1β (1–4 days) and a ∼10% decrease in myofiber size (4 days). Further, an age-specific decrease in Akt and S6 phosphorylation was observed in young muscle within the first days (1–4 days) of immobilization. In contrast, Akt phosphorylation was unchanged in old muscle after 2 days and increased after 4 days of immobilization. Further, an age-specific down-regulation of MuRF-1 and Atrogin-1 expression levels was observed following 2 weeks of immobilization, along with a slowing atrophy response in aged skeletal muscle. Neither the immediate loss of muscle mass, nor the subsequent age-differentiated signaling responses could be explained by changes in inflammatory mediators, apoptosis markers or autophagy indicators. Collectively, these findings indicate that the time-course and regulation of human skeletal muscle atrophy is age dependent, leading to an attenuated loss in aging skeletal muscle when exposed to longer periods of immobility-induced disuse.

[1]  J. Viña,et al.  Repeated muscle biopsies through a single skin incision do not elicit muscle signaling, but IL-6 mRNA and STAT3 phosphorylation increase in injured muscle. , 2011, Journal of applied physiology.

[2]  M. Kjaer,et al.  Effects of aging on muscle mechanical function and muscle fiber morphology during short-term immobilization and subsequent retraining. , 2010, Journal of applied physiology.

[3]  P. Tesch,et al.  Effects of 3 days unloading on molecular regulators of muscle size in humans. , 2010, Journal of applied physiology.

[4]  A. Goldberg,et al.  Peroxisome Proliferator-activated Receptor γ Coactivator 1α or 1β Overexpression Inhibits Muscle Protein Degradation, Induction of Ubiquitin Ligases, and Disuse Atrophy* , 2010, The Journal of Biological Chemistry.

[5]  S. M. Senf,et al.  FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70. , 2010, American journal of physiology. Cell physiology.

[6]  Per Aagaard,et al.  Molecular aging and rejuvenation of human muscle stem cells , 2009, EMBO molecular medicine.

[7]  M. Kjaer,et al.  Effects of aging on human skeletal muscle after immobilization and retraining. , 2009, Journal of applied physiology.

[8]  A. Hubbard,et al.  Limb Immobilization Induces a Coordinate Down-Regulation of Mitochondrial and Other Metabolic Pathways in Men and Women , 2009, PloS one.

[9]  S. Giovannini,et al.  Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction , 2009, Mechanisms of Ageing and Development.

[10]  G. Lanfranchi,et al.  Meta-analysis of expression signatures of muscle atrophy: gene interaction networks in early and late stages , 2008, BMC Genomics.

[11]  M. Tarnopolsky,et al.  Immobilization induces anabolic resistance in human myofibrillar protein synthesis with low and high dose amino acid infusion , 2008, The Journal of physiology.

[12]  H. Chung,et al.  Age-related activation of mitochondrial caspase-independent apoptotic signaling in rat gastrocnemius muscle , 2008, Mechanisms of Ageing and Development.

[13]  Per Aagaard,et al.  Resistance training induces qualitative changes in muscle morphology, muscle architecture, and muscle function in elderly postoperative patients. , 2008, Journal of applied physiology.

[14]  Marco Sandri,et al.  Signaling in muscle atrophy and hypertrophy. , 2008, Physiology.

[15]  K. Gundersen,et al.  In vivo time-lapse microscopy reveals no loss of murine myonuclei during weeks of muscle atrophy. , 2008, The Journal of clinical investigation.

[16]  A. Russell,et al.  Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. , 2008, Rejuvenation research.

[17]  A. Goldberg,et al.  Coordinate activation of autophagy and the proteasome pathway by FoxO transcription factor , 2008, Autophagy.

[18]  A. Goldberg,et al.  FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. , 2007, Cell metabolism.

[19]  A. Goldberg,et al.  FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.

[20]  C. Maganaris,et al.  The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse , 2007, The Journal of physiology.

[21]  Krista Vandenborne,et al.  Transcriptional pathways associated with skeletal muscle disuse atrophy in humans. , 2007, Physiological genomics.

[22]  A. Goldberg,et al.  Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  R. Wolfe,et al.  Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress. , 2006, The Journal of clinical endocrinology and metabolism.

[24]  B. Strotman,et al.  Nuclear translocation of EndoG at the initiation of disuse muscle atrophy and apoptosis is specific to myonuclei. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[25]  A. Russell,et al.  Akt signalling through GSK‐3β, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy , 2006, The Journal of physiology.

[26]  Jiandie D. Lin,et al.  PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription , 2006, Proceedings of the National Academy of Sciences.

[27]  E. Pistilli,et al.  Death receptor-associated pro-apoptotic signaling in aged skeletal muscle , 2006, Apoptosis.

[28]  G. Lanfranchi,et al.  Denervation in murine fast-twitch muscle: short-term physiological changes and temporal expression profiling. , 2006, Physiological genomics.

[29]  E. Pistilli,et al.  Molecular regulation of apoptosis in fast plantaris muscles of aged rats. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[30]  K. Conley,et al.  Reduced mitochondrial coupling in vivo alters cellular energetics in aged mouse skeletal muscle , 2005, The Journal of physiology.

[31]  E. Carmeli,et al.  The Role of NF‐κB in Protein Breakdown in Immobilization, Aging, and Exercise: From Basic Processes to Promotion of Health , 2005, Annals of the New York Academy of Sciences.

[32]  M. Wacker,et al.  Contributions of the ubiquitin–proteasome pathway and apoptosis to human skeletal muscle wasting with age , 2005, Pflügers Archiv.

[33]  E. Dupont-Versteegden Apoptosis in muscle atrophy: Relevance to sarcopenia , 2005, Experimental Gerontology.

[34]  C. Leeuwenburgh,et al.  Muscle fiber‐specific apoptosis and TNF‐α signaling in sarcopenia are attenuated by life‐long calorie restriction , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  J. Babraj,et al.  Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  D. Butler,et al.  Aging influences cellular and molecular responses of apoptosis to skeletal muscle unloading. , 2005, American journal of physiology. Cell physiology.

[37]  S. Kimball,et al.  Assessment of biomarkers of protein anabolism in skeletal muscle during the life span of the rat: sarcopenia despite elevated protein synthesis. , 2004, American journal of physiology. Endocrinology and metabolism.

[38]  A. Goldberg,et al.  IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. , 2004, American journal of physiology. Endocrinology and metabolism.

[39]  L. Andersen,et al.  The effects of heavy resistance training and detraining on satellite cells in human skeletal muscles , 2004, The Journal of physiology.

[40]  Simon W. Jones,et al.  Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  G. Yancopoulos,et al.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.

[42]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[43]  A. Goldberg,et al.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  B. Pedersen,et al.  Elevated levels of tumor necrosis factor alpha and mortality in centenarians. , 2003, The American journal of medicine.

[45]  P. Giresi,et al.  Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle , 2003, The Journal of physiology.

[46]  B. Pedersen,et al.  Age-related inflammatory cytokines and disease. , 2003, Immunology and allergy clinics of North America.

[47]  Robert Ross,et al.  Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability , 2002, Journal of the American Geriatrics Society.

[48]  S. Kandarian,et al.  Activation of an alternative NF‐ΚB pathway in skeletal muscle during disuse atrophy , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  C. Leeuwenburgh,et al.  Apoptosis in skeletal muscle with aging. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[50]  S. Kandarian,et al.  Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[52]  A. Goldberg,et al.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Yancopoulos,et al.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.

[54]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[55]  D. Lowe,et al.  The Effects of Age and Hindlimb Supension on the Levels of Expression of the Myogenic Regulatory Factors Myod and Myogenin in Rat Fast and Slow Skeletal Muscles , 2001, Experimental physiology.

[56]  L. Malmgren,et al.  Muscle Fiber and Satellite Cell Apoptosis in the Aging Human Thyroarytenoid Muscle: A Stereological Study with Confocal Laser Scanning Microscopy , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[57]  A. Goldberg,et al.  What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? , 2001, Current opinion in clinical nutrition and metabolic care.

[58]  G Bartsch,et al.  Age dependent apoptosis and loss of rhabdosphincter cells. , 2000, The Journal of urology.

[59]  M. Grounds Age‐associated Changes in the Response of Skeletal Muscle Cells to Exercise and Regeneration a , 1998, Annals of the New York Academy of Sciences.

[60]  S. Bloomfield,et al.  Changes in musculoskeletal structure and function with prolonged bed rest. , 1997, Medicine and science in sports and exercise.

[61]  R. Wolfe,et al.  Prolonged bed rest decreases skeletal muscle and whole body protein synthesis. , 1996, The American journal of physiology.

[62]  A. Goldberg,et al.  Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. , 1990, The Journal of biological chemistry.

[63]  F. Booth,et al.  Atrophy of the soleus muscle by hindlimb unweighting. , 1990, Journal of applied physiology.

[64]  F. Booth,et al.  Protein metabolism and beta-myosin heavy-chain mRNA in unweighted soleus muscle. , 1989, The American journal of physiology.

[65]  M. Rennie,et al.  Decrease in human quadriceps muscle protein turnover consequent upon leg immobilization. , 1987, Clinical science.

[66]  F. Booth,et al.  Changes in actin synthesis and alpha-actin-mRNA content in rat muscle during immobilization. , 1984, American Journal of Physiology.

[67]  F. Booth,et al.  Early change in skeletal muscle protein synthesis after limb immobilization of rats. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.

[68]  M. Brooke,et al.  Muscle fiber types: how many and what kind? , 1970, Archives of neurology.